Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of bavituximab when
administered via an arm vein as multiple infusions and to examine how bavituximab behaves in
the body and how it effects the amount of hepatitis C virus and immune modulators in
individuals with chronic infection.